๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

16 recruiting trials

for Non-small Cell Lung Cancer Stage IIIB/IV

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) NCT05920356Phase 3424 sites๐Ÿ“ Santa Barbara๐Ÿ“ Newark๐Ÿ“ Coral Springs Amgen ยท Tests: Sotorasib, Pembrolizumab Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial NCT07288034Phase 213 sites๐Ÿ“ Goodyear๐Ÿ“ Corona๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Adagrasib, Anti-PD-L1 Monoclonal Antibody, Anti-PD1 Monoclonal Antibody, Bevacizumab, Biopsy Procedure Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient NCT07198217Phase 21 site๐Ÿ“ Zibo Zibo Municipal Hospital ยท Tests: SBRT combined with Tislelizumab followed by Tislelizumab Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer๏ผšA Prospective, Single-Arm, Phase II Study NCT07085182Phase 21 site๐Ÿ“ Zibo Zibo Municipal Hospital ยท Tests: SBRT combined with Tislelizumab followed by Tislelizumab Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial NCT06096844Phase 3328 sites๐Ÿ“ Fayetteville๐Ÿ“ Fort Smith๐Ÿ“ Rogers National Cancer Institute (NCI) ยท Tests: Carboplatin, Computed Tomography, Magnetic Resonance Imaging, Nab-paclitaxel, Paclitaxel Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer NCT03819296Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Best Practice, Biospecimen Collection, Endoscopic Procedure, Fecal Microbiota Transplantation, Infliximab A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) NCT07154290Phase 218 sites๐Ÿ“ Birmingham๐Ÿ“ Goodyear๐Ÿ“ Irvine Regeneron Pharmaceuticals ยท Tests: Ubamatamab, Marlotamig, Sarilumab Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC. NCT06167460n/a1 site๐Ÿ“ Ho Chi Minh City Gene Solutions EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients NCT07096258n/a4 sites๐Ÿ“ Nancy๐Ÿ“ Naples๐Ÿ“ Madrid Hedera Dx SA Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers NCT03948100NA1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Educational Intervention, Quality-of-Life Assessment, Questionnaire Administration, Yoga Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients NCT04616209Phase 1, Phase 21 site๐Ÿ“ Taipei Precision Biotech Taiwan Corp. ยท Tests: donor-derived NK cell infusion Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change NCT03191149Phase 2347 sites๐Ÿ“ Anchorage๐Ÿ“ Anchorage๐Ÿ“ Anchorage National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Computed Tomography with Contrast, Echocardiography Test, Magnetic Resonance Imaging, Multigateโ€ฆ Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG) NCT05281406Phase 216 sites๐Ÿ“ Berlin๐Ÿ“ Cologne๐Ÿ“ Dresden Goethe University ยท Tests: Osimertinib, Pemetrexed, Cisplatin, Carboplatin Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer NCT04181060Phase 3603 sites๐Ÿ“ Anchorage๐Ÿ“ Anchorage๐Ÿ“ Anchorage National Cancer Institute (NCI) ยท Tests: Bevacizumab, Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381Phase 1, Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab, Sargramostim, Biospecimen Collection AK129 Combination Therapy for Advanced Solid Tumors NCT06943820Phase 1, Phase 21 site๐Ÿ“ Shenyang Akeso ยท Tests: AK129(dose 1), Pemetrexed, Paclitaxel, Carboplatin, AK129(dose 2)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy